Medical Weight Loss for Murrieta, California Residents

Murrieta, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Murrieta through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Murrieta: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps California patients choose. Doctor review just $119 (medication separate).

Why Murrieta Residents Choose New Hope Weight Loss

Some patients in Murrieta are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Murrieta is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

If you are searching for a weight-loss physician in Murrieta, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts California patients exactly where local ones are. We care for patients throughout historic downtown Murrieta and the southwest Riverside County area. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Murrieta.

Patients on the outskirts of California get the same flat pricing, the same physician, and the same fast start as those near the center of Murrieta. If you and Dr. Sharma decide tirzepatide fits your goals, Murrieta patients can begin from $233 per month, billed apart from your initial $119 visit. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Murrieta choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Murrieta

The path from curious to treated is short, and it all runs through your screen. People in Murrieta start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Murrieta home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Murrieta

Does New Hope Weight Loss have a presence in Murrieta?

Our presence in Murrieta is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Murrieta, California patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Murrieta patient complete care without leaving home?

Yes, staying home is the norm. Everything for Murrieta patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Murrieta in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Murrieta patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Murrieta.

What areas of Murrieta do you serve?

We serve patients from across Murrieta by telehealth, including historic downtown Murrieta and the southwest Riverside County area.

Is bilingual (Spanish) telehealth care available for Murrieta patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Murrieta patients.

Murrieta Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Murrieta, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.